PortfoliosLab logoPortfoliosLab logo
CURE vs. SOXL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CURE vs. SOXL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Semiconductor Bull 3X ETF (SOXL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -18.38% return, which is significantly lower than SOXL's 567.48% return. Over the past 10 years, CURE has underperformed SOXL with an annualized return of 11.65%, while SOXL has yielded a comparatively higher 65.39% annualized return.


CURE

1D
2.17%
1M
4.39%
YTD
-18.38%
6M
-18.70%
1Y
21.60%
3Y*
-0.15%
5Y*
0.21%
10Y*
11.65%

SOXL

1D
5.34%
1M
119.95%
YTD
567.48%
6M
502.28%
1Y
1,438.30%
3Y*
135.13%
5Y*
48.72%
10Y*
65.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. SOXL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
-18.38%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
SOXL
Direxion Daily Semiconductor Bull 3X ETF
567.48%54.91%-12.31%226.98%-85.66%118.84%70.04%231.83%-39.07%141.71%

Correlation

The correlation between CURE and SOXL is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (10Y)
Calculated over the trailing 10-year period

0.41

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.47

Over the past year, the correlation between CURE and SOXL has dropped to 0.15 - well below their long-term average of 0.47, suggesting their price drivers have been diverging.

CURE vs. SOXL - Sectors Allocation Comparison


Sectors
CURE
SOXL

Healthcare

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

100.0%

Utilities

-

-

Healthcare

CURE
100.0%
SOXL

-

Basic Materials

CURE

-

SOXL

-

Communication Services

CURE

-

SOXL

-

Consumer Cyclical

CURE

-

SOXL

-

Consumer Defensive

CURE

-

SOXL

-

Energy

CURE

-

SOXL

-

Financial Services

CURE

-

SOXL

-

Industrials

CURE

-

SOXL

-

Real Estate

CURE

-

SOXL

-

Technology

CURE

-

SOXL
100.0%

Utilities

CURE

-

SOXL

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CURE vs. SOXL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
CURE Risk / Return Rank: 1818
Overall Rank
CURE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 1919
Sortino Ratio Rank
CURE Omega Ratio Rank: 1818
Omega Ratio Rank
CURE Calmar Ratio Rank: 1717
Calmar Ratio Rank
CURE Martin Ratio Rank: 1717
Martin Ratio Rank

SOXL
SOXL Risk / Return Rank: 9797
Overall Rank
SOXL Sharpe Ratio Rank: 100100
Sharpe Ratio Rank
SOXL Sortino Ratio Rank: 9595
Sortino Ratio Rank
SOXL Omega Ratio Rank: 9595
Omega Ratio Rank
SOXL Calmar Ratio Rank: 9999
Calmar Ratio Rank
SOXL Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. SOXL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Semiconductor Bull 3X ETF (SOXL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CURESOXLDifference
Sharpe ratioReturn per unit of total volatility

-13.78

Sortino ratioReturn per unit of downside risk

-4.14

Omega ratioGain probability vs. loss probability

1.12

1.72

-0.60

Calmar ratioReturn relative to maximum drawdown

0.70

33.47

-32.77

Martin ratioReturn relative to average drawdown

1.61

114.79

-113.18

CURE vs. SOXL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.50, which is lower than the SOXL Sharpe Ratio of 14.28. The chart below compares the historical Sharpe Ratios of CURE and SOXL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CURESOXLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.50

14.28

-13.78

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.00

0.46

-0.45

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.24

0.66

-0.43

Sharpe Ratio (All Time)

Calculated using the full available price history

0.46

0.52

-0.06

Drawdowns

CURE vs. SOXL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum SOXL drawdown of -90.46%. Use the drawdown chart below to compare losses from any high point for CURE and SOXL.


Loading charts...

Drawdown Indicators


CURESOXLDifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-90.46%

+21.27%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-43.47%

+12.37%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-87.88%

+35.95%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-90.46%

+38.23%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-90.46%

+21.27%

Current Drawdown

Current decline from peak

-35.21%

0.00%

-35.21%

Average Drawdown

Average peak-to-trough decline

-18.15%

-35.01%

+16.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.43%

12.65%

+0.78%

Volatility

CURE vs. SOXL - Volatility Comparison

The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 11.99%, while Direxion Daily Semiconductor Bull 3X ETF (SOXL) has a volatility of 40.82%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than SOXL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CURESOXLDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.99%

40.82%

-28.83%

Volatility (6M)

Calculated over the trailing 6-month period

29.83%

81.29%

-51.46%

Volatility (1Y)

Calculated over the trailing 1-year period

43.19%

102.11%

-58.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.69%

107.25%

-63.56%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.51%

99.04%

-49.53%

CURE vs. SOXL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than SOXL's 0.75% expense ratio.


Dividends

CURE vs. SOXL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.31%, more than SOXL's 0.03% yield.


PositionTTM2025202420232022202120202019201820172016
CURE
Direxion Daily Healthcare Bull 3x Shares
1.31%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%
SOXL
Direxion Daily Semiconductor Bull 3X ETF
0.03%0.34%1.18%0.51%1.07%0.04%0.05%0.38%1.30%0.09%4.84%

Frequently Asked Questions


CURE and SOXL have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SOXL has higher volatility (40.82%) compared to CURE (11.99%). In terms of maximum drawdown, CURE dropped -69.19% vs SOXL's -90.46%.

On 10-year performance, SOXL leads with 65.39% vs 11.65% for CURE. On fees, SOXL is cheaper at 0.75% per year. On volatility, CURE has been the lower-risk option at 11.99%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SOXL has performed better with a 65.39% return vs 11.65%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SOXL is cheaper with a 0.75% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.31%, compared with 0.03% for SOXL.

CURE tracks Health Care Select Sector Index (300%), while SOXL tracks ICE Semiconductor Index. Their fees differ too: 1.08% for CURE and 0.75% for SOXL.

SOXL currently has the higher Sharpe Ratio (14.28 vs 0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and SOXL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer